BNP Paribas Asset Management
ABMD

BNP Paribas Asset Management’s Abiomed Inc ABMD Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-63,704
Closed -$15.7M 933
2022
Q3
$15.7M Buy
63,704
+1,425
+2% +$350K 0.06% 330
2022
Q2
$15.4M Buy
62,279
+8,186
+15% +$2.03M 0.06% 323
2022
Q1
$17.9M Buy
54,093
+12,485
+30% +$4.14M 0.06% 318
2021
Q4
$14.9M Buy
41,608
+20,501
+97% +$7.36M 0.05% 370
2021
Q3
$6.87M Buy
21,107
+136
+0.6% +$44.3K 0.03% 483
2021
Q2
$6.55M Sell
20,971
-2,284
-10% -$713K 0.02% 509
2021
Q1
$7.41M Buy
23,255
+194
+0.8% +$61.8K 0.03% 459
2020
Q4
$7.48M Buy
23,061
+3,040
+15% +$986K 0.03% 431
2020
Q3
$5.55M Buy
20,021
+2,772
+16% +$768K 0.03% 417
2020
Q2
$4.17M Buy
17,249
+2,879
+20% +$696K 0.03% 464
2020
Q1
$2.09M Buy
14,370
+1,085
+8% +$158K 0.02% 537
2019
Q4
$2.27M Buy
13,285
+10,778
+430% +$1.84M 0.02% 579
2019
Q3
$446K Sell
2,507
-28,591
-92% -$5.09M ﹤0.01% 749
2019
Q2
$8.1M Buy
31,098
+2,856
+10% +$744K 0.07% 338
2019
Q1
$8.07M Buy
28,242
+19,009
+206% +$5.43M 0.07% 344
2018
Q4
$2.94M Sell
9,233
-6,391
-41% -$2.03M 0.03% 541
2018
Q3
$7.03M Buy
15,624
+5,799
+59% +$2.61M 0.05% 414
2018
Q2
$4.02M Sell
9,825
-28,366
-74% -$11.6M 0.03% 522
2018
Q1
$11.1M Sell
38,191
-20,859
-35% -$6.07M 0.09% 304
2017
Q4
$11.1M Sell
59,050
-71,302
-55% -$13.4M 0.09% 314
2017
Q3
$22M Sell
130,352
-10,902
-8% -$1.84M 0.19% 138
2017
Q2
$20.2M Sell
141,254
-223
-0.2% -$32K 0.18% 131
2017
Q1
$17.7M Buy
141,477
+15,221
+12% +$1.91M 0.16% 155
2016
Q4
$14.2M Buy
126,256
+38,866
+44% +$4.38M 0.14% 195
2016
Q3
$11.2M Sell
87,390
-37,816
-30% -$4.86M 0.1% 286
2016
Q2
$13.7M Sell
125,206
-19,705
-14% -$2.15M 0.12% 239
2016
Q1
$13.7M Sell
144,911
-15,023
-9% -$1.42M 0.12% 243
2015
Q4
$14.4M Buy
159,934
+9,885
+7% +$892K 0.12% 222
2015
Q3
$13.9M Sell
150,049
-47,005
-24% -$4.36M 0.12% 242
2015
Q2
$13M Buy
197,054
+4,849
+3% +$319K 0.1% 271
2015
Q1
$13.8M Buy
192,205
+91,929
+92% +$6.58M 0.11% 271
2014
Q4
$3.82M Buy
+100,276
New +$3.82M 0.03% 490